Fas Sensitivity in B-cell Non-Hodgkin's Lymphomas
Author Information
Author(s): L Xerri, R Bouabdallah, E Devilard, J Hassoun, A-M Stoppa, F Birg
Primary Institution: Institut Paoli-Calmettes, Marseilles; INSERM U 119, Marseilles, France
Hypothesis
The sensitivity of B-cell non-Hodgkin's lymphomas (NHLs) to Fas-mediated apoptosis can be modulated by CD40 ligation.
Conclusion
The study found that sensitivity to Fas-induced apoptosis is generally weak in NHL cells but can be moderately increased by CD40 activation.
Supporting Evidence
- The fraction of Fas-expressing lymphoma cells varied significantly among samples, with a mean of 46%.
- CD40 ligation resulted in significant increases in Fas expression and apoptosis in some B-NHL cases.
- No significant increase in apoptosis was observed with anti-Fas treatment compared to control MAb in the majority of cases.
- Fas resistance was not correlated with histological subtype or Fas expression levels.
Takeaway
This study looked at how cancer cells from lymphomas respond to a signal that usually makes cells die. They found that these cancer cells don't respond well, but a special treatment can help a little.
Methodology
The study analyzed 18 NHL biopsy samples for Fas expression and sensitivity to Fas-mediated apoptosis using flow cytometry and CD40 induction.
Limitations
The number of lymphoma cases analyzed is relatively small, which may limit the generalizability of the findings.
Participant Demographics
The study included untreated patients with various subtypes of B-cell non-Hodgkin's lymphomas.
Statistical Information
Statistical Significance
p>0.1
Want to read the original?
Access the complete publication on the publisher's website